AllistairAbrahamMD
Pediatric Hematology & Oncology • Washington, DCAssistant Professor, Pediatrics, George Washington University Sch of Med and Health Sciences
Are you Dr. Abraham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 95 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-476-6690
Summary
- Dr. Allistair Abraham, MD is a pediatric hematologist/oncologist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia, Virginia, and Tennessee. He is affiliated with Children's National Hospital and is an Assistant Professor at George Washington University Sch of Med and Health Sciences.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2008 - 2011
University of Miami/Jackson Health SystemResidency, Pediatrics, 2005 - 2008
Georgetown University School of MedicineClass of 2005
Certifications & Licensure
DC State Medical License 2012 - 2022
VA State Medical License 2012 - 2022
TN State Medical License 2008 - 2012
Clinical Trials
- Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease Start of enrollment: 2012 Mar 01
- Minimizing Toxicity in HLA-identical Related Donor Transplantation for Children With Sickle Cell Disease Start of enrollment: 2018 Apr 17
- Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis Start of enrollment: 2018 Jan 24
Publications & Presentations
PubMed
- 26 citationsCurative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?Alexis Leonard, John F. Tisdale, Allistair Abraham
British Journal of Haematology. 2020-02-07 - 6 citationsTransplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem...Orly R Klein, Carmem Bonfim, Allistair Abraham, Annalisa Ruggeri, Duncan Purtill
Cytotherapy. 2023-05-01 - 39 citationsClinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databasesStaci D. Arnold, Ruta Brazauskas, Naya He, Yimei Li, Richard Aplenc
Haematologica. 2017-11-01
Press Mentions
New Clinical Trial Gives Hope to Sickle Cell PatientsSeptember 25th, 2019
